• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study

    Credits

    3 Contact Hour(s)

    Release Date

    Saturday, April 22, 2017

    Offline Date

    Wednesday, April 22, 2020

    ACPE Expiration Date

    Wednesday, April 22, 2020

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $21.00

    • Overview

      We live in an "Opioid Epidemic" where someone dies approximately every 15 minutes from prescription drug overdose. So just how do we end this "Opioid Epidemic" or at least, how do we as healthcare professionals contribute to the progress of society in the right direction? In this monograph, we will review overall pain management etiology, specific opioid medication pharmacological concepts, opioid overdose reversal treatments, and not only how to identify drug seeking and diversion behaviors, but possible actions to take when the behaviors are suspected. We will also review West Virginia specific controlled substance laws, trends, and the Controlled Substances Monitoring Program. Unlike opioids, this monograph is intended to open one's eyes, elevate blood pressure and/or heart rate, and increase cognition (in relation to the Opioid Epidemic).

       

      This program has been APPROVED for WV Pharmacists to fulfill the requirement of Drug Diversion.  WV-2017-05-10-CE Drug Diversion

      Rating

         4.50  out of 5

      Handouts

      • Homestudy PDF :   HomestudyPDF17096H04.pdf

      Financial Support By

      PharmCon
    • Pharmacist

      Describe when and how to initiation, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; discontinuation and tapering of opioids; medication therapy management and collaborative practice; and appropriate documentation in medical records.
      Describe the etiology and epidemiology of chronic pain.
      Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.
      Identify West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.
      Explain how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-l.
      Explain the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.
      Describe the best practices for identifying “red flag” patient drug seeking & diversion behaviors.
      Explain how to be compliant with federal and state controlled substances laws.
      Explain the best practices for working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.

      Pharmacy Technician

      Identify West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.
      Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.
      Identify the best practices for the use of opioid medications based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; & discontinuation and tapering of opioids.
      Explain how to be compliant with federal and state controlled substance laws
      Explain how to ensure that the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment are in place within a pharmacy practice
      Describe the etiology and epidemiology of chronic pain.
      Explain the best practices for working with patients, prescribers, law enforcement, and other as appropriate, concerning patients suspected of drug seeking behavior and diversion
      Describe the best practices for identifying "red flag" patient drug seeking & diversion behaviors
      Explain how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-l.

      Nurse

      Explain how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-l.
      Identify West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.
      Describe when and how to initiation, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; discontinuation and tapering of opioids; medication therapy management and collaborative practice; and appropriate documentation in medical records.
      Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.
      Explain how to be compliant with federal and state controlled substances laws.
      Describe the etiology and epidemiology of chronic pain.
      Describe the best practices for identifying “red flag” patient drug seeking & diversion behaviors.
      Explain the best practices for working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.
      Explain the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.
    • Activity Type

      Knowledge

      CE Broker

      20-606442

      Universal Activity Number

      Pharmacist 0798-0000-17-096-H04-P
      Pharmacy Technician 0798-0000-17-096-H04-T
      Nurse 0798-0000-17-096-H04-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher
    Adobe Acrobat Reader


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).